CycloheterophyllinCAS# 36545-53-6 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 36545-53-6 | SDF | Download SDF |
| PubChem ID | 5316250 | Appearance | Yellow powder |
| Formula | C30H30O7 | M.Wt | 502.56 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC(=CCC1=C2C(=C(C3=C1OC4=C(C3=O)C(OC5=CC(=C(C=C54)O)O)C=C(C)C)O)C=CC(O2)(C)C)C | ||
| Standard InChIKey | ZZPIXEJZTXAVCX-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C30H30O7/c1-14(2)7-8-17-27-16(9-10-30(5,6)37-27)25(33)24-26(34)23-22(11-15(3)4)35-21-13-20(32)19(31)12-18(21)29(23)36-28(17)24/h7,9-13,22,31-33H,8H2,1-6H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Cycloheterophyllin exerts a concentration-dependent inhibition of neutrophil cytosolic protein kinase C (PKC) and rat brain PKC by the O2- generation in rat neutrophils, but has no effect on porcine heart protein kinase A (PKA). 2. Cycloheterophyllin has an antioxidant effect and can effectively scavenge free radicals. 3. Cycloheterophyllin is a photoprotective agent that inhibits ultraviolet A (UVA)-induced oxidative stress and damage, and could be used in the research on and prevention of skin photoaging. 4. Cycloheterophyllin shows strong inhibition of arachidonic acid (AA)-induced platelet aggregation, due to an inhibitory effect on cyclooxygenase. |
| Targets | PKA | PKC | NADPH-oxidase | NF-kB | Caspase | MAPK |
Cycloheterophyllin Dilution Calculator
Cycloheterophyllin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.9898 mL | 9.9491 mL | 19.8981 mL | 39.7962 mL | 49.7453 mL |
| 5 mM | 0.398 mL | 1.9898 mL | 3.9796 mL | 7.9592 mL | 9.9491 mL |
| 10 mM | 0.199 mL | 0.9949 mL | 1.9898 mL | 3.9796 mL | 4.9745 mL |
| 50 mM | 0.0398 mL | 0.199 mL | 0.398 mL | 0.7959 mL | 0.9949 mL |
| 100 mM | 0.0199 mL | 0.0995 mL | 0.199 mL | 0.398 mL | 0.4975 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Guaiacin
Catalog No.:BCN4127
CAS No.:36531-08-5
- Serpentinine
Catalog No.:BCN5325
CAS No.:36519-42-3
- Emiline
Catalog No.:BCN2080
CAS No.:36506-99-7
- beta-Costic acid
Catalog No.:BCN5324
CAS No.:3650-43-9
- Agatholal
Catalog No.:BCN5323
CAS No.:3650-31-5
- Carnosic acid
Catalog No.:BCN5892
CAS No.:3650-09-7
- Methylsynephrine Hydrochloride
Catalog No.:BCN3407
CAS No.:365-26-4
- Cinacalcet HCl
Catalog No.:BCC4408
CAS No.:364782-34-3
- Ginsenoside Rk3
Catalog No.:BCN3502
CAS No.:364779-15-7
- Ginsenoside Rk2
Catalog No.:BCN3721
CAS No.:364779-14-6
- Doripenem Hydrate
Catalog No.:BCC1160
CAS No.:364622-82-2
- Lucidenic acid SP1
Catalog No.:BCN7969
CAS No.:364622-33-3
- Ac-Tyr-OEt.H2O
Catalog No.:BCC3121
CAS No.:36546-50-6
- H-Arg-OEt.2HCl
Catalog No.:BCC2860
CAS No.:36589-29-4
- Procarbazine HCl
Catalog No.:BCC4452
CAS No.:366-70-1
- AY 9944 dihydrochloride
Catalog No.:BCC3940
CAS No.:366-93-8
- Mubritinib (TAK 165)
Catalog No.:BCC4513
CAS No.:366017-09-6
- 1,4-Benzodioxan-2-carboxylic acid
Catalog No.:BCC8421
CAS No.:3663-80-7
- Semialactone
Catalog No.:BCN5422
CAS No.:366450-46-6
- 1-Hexadecanol
Catalog No.:BCC4616
CAS No.:36653-82-4
- Rivaroxaban
Catalog No.:BCC2292
CAS No.:366789-02-8
- Cussosaponin C
Catalog No.:BCN2895
CAS No.:366814-42-8
- Pulchinenoside E
Catalog No.:BCN8165
CAS No.:366814-43-9
- Isorhamnetin 3-glucuronide
Catalog No.:BCN2709
CAS No.:36687-76-0
Blockade of protein kinase C is involved in the inhibition by cycloheterophyllin of neutrophil superoxide anion generation.[Pubmed:9151291]
Naunyn Schmiedebergs Arch Pharmacol. 1997 May;355(5):551-8.
Cycloheterophyllin, a prenylflavone, inhibited the superoxide anion (O2-) generation from formylmethionyl-leucyl-phenylalanine (fMLP)- and phorbol 12-myristate 13-acetate (PMA)-stimulated rat neutrophils in a concentration-dependent manner with IC50 values of 47.0 +/- 5.0 and 1.7 +/- 0.4 microM, respectively. Cycloheterophyllin had no effect on O2- generation in xanthine-xanthine oxidase system and during dihydroxyfumaric acid (DHF) autoxidation. Cycloheterophyllin exerted a concentration-dependent inhibition of neutrophil cytosolic protein kinase C (PKC) and rat brain PKC, but had no effect on porcine heart protein kinase A (PKA). Unlike staurosporine, Cycloheterophyllin did not affect the trypsin-treated rat brain PKC. [3H]Phorbol 12,13-dibutyrate ([3H]PDB) binding to neutrophil cytosolic PKC was significantly suppressed by Cycloheterophyllin. However, Cycloheterophyllin had negligible effect on the PMA-induced membrane translocation of PKC-beta and PKC-delta in neutrophils. Moreover, the fMLP-induced [Ca2+]i elevation and inositol trisphosphate (IP3) formation of neutrophils were not affected by Cycloheterophyllin at concentrations which significantly suppressed the O2- generation. In cell-free system, addition of arachidonate (AA) into the mixture of cytosol and membrane fractions of the resting neutrophils to make NADPH oxidase assembly and activation. Cycloheterophyllin had no effect on O2- generation in AA-activated cell-free system. These results suggest that the suppression of PKC activity through the interaction with the regulatory region of PKC is involved in the inhibition by Cycloheterophyllin of the O2- generation in rat neutrophils.
Photoprotective Effects of Cycloheterophyllin against UVA-Induced Damage and Oxidative Stress in Human Dermal Fibroblasts.[Pubmed:27583973]
PLoS One. 2016 Sep 1;11(9):e0161767.
Ultraviolet (UV) radiation, particularly ultraviolet A (UVA), is known to play a major role in photoaging of the human skin. Many studies have demonstrated that UV exposure causes the skin cells to generate reactive oxygen species and activates the mitogen-activated protein kinase (MAPK) pathway. Previous studies have also demonstrated that Cycloheterophyllin has an antioxidant effect and can effectively scavenge free radicals. Extending the aforementioned investigations, in this study, human dermal fibroblasts were used to investigate the protective effect of Cycloheterophyllin against UV-induced damage. We found that Cycloheterophyllin not only significantly increased cell viability, but also attenuated the phosphorylation of MAPK after UVA exposure. Furthermore, Cycloheterophyllin could reduce hydrogen peroxide (H2O2) generation and down-regulate H2O2-induced MAPK phosphorylation. In the in vivo studies, the topical application of Cycloheterophyllin before UVA irradiation significantly decreased trans-epidermal water loss (TEWL), erythema, and blood flow rate. These results indicate that Cycloheterophyllin is a photoprotective agent that inhibits UVA-induced oxidative stress and damage, and could be used in the research on and prevention of skin photoaging.
Novel antiplatelet constituents from formosan moraceous plants.[Pubmed:8864236]
J Nat Prod. 1996 Sep;59(9):834-8.
Sixteen constituents from Formosan Moraceous plants were tested for their antiplatelet activities in rabbit platelet suspension and human platelet-rich plasma. Cycloartocarpin A, Cycloheterophyllin, broussochalcone A, kazinol A, broussoaurone A, and broussoflavonol F showed strong inhibition of arachidonic acid (AA)-induced platelet aggregation. Of the compounds tested, broussochalcone A exhibited the most potent inhibition of platelet aggregation induced by AA (IC50 = 6.8 microM). The antiplatelet effects of Cycloheterophyllin, broussochalcone A, kazinol B, broussoaurone A, and broussoflavonol F are partially due to an inhibitory effect on cyclooxygenase.
